Evaluation of Bacillus Subtilis R0179 in Healthy Young Adults
Completed · Not applicable · Has a placebo group
Conditions studied: Healthy
In brief
The purpose of this study is to evaluate the effect of three doses of the probiotic B. subtilis (Bacillus subtilis R0179) delivered in capsules on gastrointestinal and general wellness in healthy young adults, survival through the gastrointestinal tract and impact on intestinal microbes.
Key facts
- Study ID
- NCT01802151
- Run by
- University of Florida
- People needed
- 83
- Starts
- 2012-07-01
- Expected to finish
- 2012-10-01
- Last updated by the study team
- 2015-12-17
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Florida — Gainesville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.